Atovaquone
Active substance: atovaquone
SUSPENSION · ATOVAQUONE 750 mg/5mL
United StatesActive
Marketing holder: NorthStar RxLLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- ATOVAQUONE · 750 mg/5mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-469a-75b4-91e9-57c197eab1f1,01a1208c-4b3d-70cb-9c98-0a8b89e86568,01a1208c-501a-7407-9b94-f2ba09543dc0,01a1208c-845b-78db-953b-83b3d306a9e6,01a1208c-d951-720d-91ea-92c87708b4b4;count=24 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 72603-248
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 72603-248 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 72603-248 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 72603-248 · Verified 2026-10-09 · open in source